Ikapharmindo Putramas Tbk. vs Summarecon Agung Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume), while Summarecon Agung Tbk. trades at Rp330 (market cap 5.38T, 14.47M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 16.3× Ikapharmindo Putramas Tbk.'s market cap, and Summarecon Agung Tbk. is more actively traded (14.47M versus 215.9K). Which is the better fit depends on your goals.
| IKPM | SMRA | |
|---|---|---|
Market Cap | 330.19B | 5.38T |
Volume | 215.9K | 14.47M |
Lot | 2.16K | 144.72K |
Turnover | 42.44M | 4.76B |
Average Price | 196.56 | 329.12 |
Value | 42.44M | 4.76B |
Indicative Equilibrium Price | 199 | 330 |
Indicative Equilibrium Volume | 9 | 3.11K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →